BCL2 and neoplasm: In contrast, miR-503 expression has been reported to be upregulated in certain cancers and identified as a tumor-associated miRNA that directly targets Bcl2 apoptosis regulator to promote apoptosis of dendritic cells, indicating a mechanism for tumor immunotolerance (Min et al., 2013).